CDEK by Data4ThePeople
Drugs
Search by NameFDA Approval TrendsAdvanced SearchFDA Approved Drugs
Organizations
Search by NameOrganization TrendsAdvanced Search
IndicationsMechanismsTrialsFDA Approvals
About
About CDEKGlossaryAdvanced Search GuideSearch by Name
Drugs
Search by NameFDA Approval TrendsAdvanced SearchFDA Approved Drugs
Organizations
Search by NameOrganization TrendsAdvanced Search
IndicationsMechanismsTrialsFDA Approvals
About
About CDEKGlossaryAdvanced Search GuideSearch by Name
← All indications

Diabetic Ketoacidosis

A life-threatening complication of diabetes mellitus, primarily of TYPE 1 DIABETES MELLITUS with severe INSULIN deficiency and extreme HYPERGLYCEMIA. It is characterized by KETOSIS; DEHYDRATION; and depressed consciousness leading to COMA.

Drugs by status

Phase 4 trials (5)

  • ringer's lactate
  • insulin glulisine
  • insulin glargine
  • insulin human
  • sodium chloride

Phase 3 trials (3)

  • meglumine
  • potassium chloride
  • glucose monohydrate

Phase 2 trials (2)

  • thiamine
  • arginine

Phase 1 trials (1)

  • dapagliflozin

Other trials (4)

  • insulin lispro
  • pioglitazone
  • ketone monoester
  • 3-hydroxybutyrate

Organizations

Organization Involved with Phase 4 Indications (4)

  • Sanofi
  • Emory University
  • University of Minnesota
  • The Cleveland Clinic

Organization Involved with Phase 2 Indications (3)

  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
  • Harvard University
  • University of Colorado, Denver

Organization Involved with Phase 1 Indications (1)

  • Gottfried Wilhelm Leibniz Universität Hannover

Organization Involved with Other Experimental Indications (12)

  • Novo Nordisk
  • Aarhus University
  • Chattanooga-Hamilton County Hospital Authority
  • University of Maryland
  • State University of New York
  • Vanderbilt University
  • Rush University
  • Hennepin Healthcare
  • University of Texas at Houston
  • State University of New York, Buffalo
  • Linkoping University
  • Vrinnevi Hospital

CDEK

The Clinical Drug Experience Knowledgebase — tracking drugs, sponsoring organizations, and clinical trials from first-in-human testing through approval.

Browse

  • Drugs
  • Organizations
  • Trials

About

  • About CDEK
  • Glossary

Built and maintained by Data4ThePeople.

YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED "AS IS", WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.